Jennerex Raises $5.1 Million for Oncology Pipeline
Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.
Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.
Two pharmaceutical companies are eager to advance a different approach to treating lung cancer.
HealthTronics announced that it has entered into a definitive merger agreement with Endocare.
Eight studies presented this week at the American Urological Association Annual Meeting suggest that Gen-Probe’s investigational test for the prostate cancer gene PCA3 may address some of the major challenges faced by urologists when diagnosing the disease.
Copyright © 2024 | WordPress Theme by MH Themes